Hogan Lovells advised Soliton on the deal. Allergan Aesthetics, an AbbVie company, will acquire Soliton and RESONIC, its Rapid Acoustic Pulse device, for approximately US$550 million....
This content is for Standard 1 Year members only. LoginJoin Now